Search

everythinglearnresearchcommunity

for

Search:↓

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

SHBG may be a useful early indicator and treatment target for PCOS.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Alternative treatments show promise for hair growth beyond traditional methods.

Curcumin may help reverse aging by targeting specific genes.

The woman's surgery lowered her testosterone and improved scalp hair loss but did not change her excessive body hair.

Early treatment of acne is crucial to prevent scarring and psychological effects.

Clinicians should use social and prescription data to track trends in performance-enhancing drug use.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

Both genetic and lifestyle factors significantly affect female hair loss.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

Excess androgens may cause PCOS, not just be a symptom.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.